Your search returned 2 results.

Results
	1.	A placebo-controlled study investigating the efficacy and safety of the phosphodiesterase type 5 inhibitor UK-369,003 for the treatment of men with lower urinary tract symptoms associated with clinical benign prostatic hyperplasia. [electronic resource] by Tamimi, Nihad A M Mincik, Ivan Haughie, Scott Lamb, Janice Crossland, Anna Ellis, Peter Producer: 20101207 In: BJU international vol. 106 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	A phase 3, open-label, multicenter study of a 6-month pre-mixed depot formulation of leuprolide mesylate in advanced prostate cancer patients. [electronic resource] by Shore, Neal Mincik, Ivan DeGuenther, Mark Student, Vladimir Jievaltas, Mindaugas Patockova, Jitka Simpson, Kelle Hu, Chu-Hsuan Huang, Shih-Tsung Li, Yuhua Lee, Yisheng Chien, Ben Mao, John Producer: 20201111 In: World journal of urology vol. 38 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search